Top-Rated StocksTop-RatedNYSE:EVH Evolent Health (EVH) Stock Price, News & Analysis → Major Elon Musk Crypto Leak Revealed (From Crypto 101 Media) (Ad) Free EVH Stock Alerts $32.79 +0.06 (+0.18%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$32.40▼$33.3050-Day Range$29.41▼$34.7452-Week Range$23.33▼$36.70Volume830,006 shsAverage Volume989,808 shsMarket Capitalization$3.78 billionP/E RatioN/ADividend YieldN/APrice Target$42.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Evolent Health alerts: Email Address Evolent Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.92 Rating ScoreUpside/Downside30.2% Upside$42.70 Price TargetShort InterestBearish9.36% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.46Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth58.62%From $0.87 to $1.38 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.32 out of 5 starsComputer And Technology Sector274th out of 588 stocksManagement Services Industry4th out of 5 stocks 4.5 Analyst's Opinion Consensus RatingEvolent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $42.70, Evolent Health has a forecasted upside of 30.2% from its current price of $32.79.Amount of Analyst CoverageEvolent Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.36% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 11, which indicates bearish sentiment.Change versus previous monthShort interest in Evolent Health has recently decreased by 3.83%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EVH. Previous Next 3.6 News and Social Media Coverage News SentimentEvolent Health has a news sentiment score of 1.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Evolent Health this week, compared to 3 articles on an average week.Search Interest2 people have searched for EVH on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -57% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.30% of the stock of Evolent Health is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Evolent Health are expected to grow by 58.62% in the coming year, from $0.87 to $1.38 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -25.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -25.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 3.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Evolent Health Stock (NYSE:EVH)Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Read More EVH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EVH Stock News HeadlinesMarch 26, 2024 | americanbankingnews.comEvolent Health, Inc. (NYSE:EVH) Given Average Recommendation of "Moderate Buy" by AnalystsMarch 19, 2024 | americanbankingnews.comEvolent Health (NYSE:EVH) Price Target Cut to $52.00 by Analysts at JPMorgan Chase & Co.March 28, 2024 | Crypto 101 Media (Ad)Altcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… March 16, 2024 | finance.yahoo.comEVH Apr 2024 27.500 putMarch 15, 2024 | markets.businessinsider.comNavigating 4 Analyst Ratings For Evolent HealthMarch 1, 2024 | msn.comOppenheimer Initiates Coverage of Evolent Health (EVH) with Outperform RecommendationFebruary 27, 2024 | finance.yahoo.comWall Street Analysts Predict a 35.7% Upside in Evolent Health (EVH): Here's What You Should KnowFebruary 26, 2024 | finance.yahoo.comHere's What Analysts Are Forecasting For Evolent Health, Inc. (NYSE:EVH) After Its Annual ResultsMarch 28, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. February 24, 2024 | finance.yahoo.comEvolent Health Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 23, 2024 | markets.businessinsider.comThese Analysts Revise Their Forecasts On Evolent Health After Upbeat ResultsFebruary 23, 2024 | markets.businessinsider.comAnalyst Scoreboard: 4 Ratings For Evolent HealthFebruary 23, 2024 | finanznachrichten.deEvolent Health: Evolent Announces Fourth Quarter and Full Year 2023 ResultsFebruary 23, 2024 | markets.businessinsider.comBarclays Reaffirms Their Buy Rating on Evolent Health (EVH)February 23, 2024 | markets.businessinsider.comEvolent Health (EVH) Buy Rating Affirmed Amid Strong Q4 Results and Promising 2024 ProjectionsFebruary 23, 2024 | investing.comEvolent Health Inc (EVH)February 22, 2024 | benzinga.comEvolent Health Stock (NYSE:EVH) Insider TradesFebruary 22, 2024 | finance.yahoo.comEvolent Health Inc (EVH) Reports Robust Revenue Growth and Improved Adjusted EBITDA in 2023February 22, 2024 | prnewswire.comEvolent Announces Fourth Quarter and Full Year 2023 ResultsFebruary 22, 2024 | benzinga.comEvolent Health Stock (NYSE:EVH) Dividends: History, Yield and DatesFebruary 20, 2024 | msn.comTeladoc Health slides ~16% after hours as 2024 guidance, long-term outlook disappointsFebruary 15, 2024 | seekingalpha.comEVH Evolent Health, Inc.February 14, 2024 | finance.yahoo.comEvolent Adds Russell Glass, Headspace CEO, to Board of DirectorsFebruary 14, 2024 | prnewswire.comEvolent Adds Russell Glass, Headspace CEO, to Board of DirectorsJanuary 31, 2024 | markets.businessinsider.comPositive Outlook for Evolent Health with Anticipated EBITDA Growth and Strategic Deals Reinforcing Buy RatingJanuary 25, 2024 | finance.yahoo.comEvolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024January 22, 2024 | finance.yahoo.comNew Strong Buy Stocks for January 5thSee More Headlines Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/22/2024Today3/28/2024Next Earnings (Estimated)5/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Management services Sub-IndustryN/A Current SymbolNYSE:EVH CUSIPN/A CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees4,700Year FoundedN/APrice Target and Rating Average Stock Price Target$42.70 High Stock Price Target$52.00 Low Stock Price Target$34.00 Potential Upside/Downside+30.5%Consensus RatingModerate Buy Rating Score (0-4)2.92 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)($1.27) Trailing P/E RatioN/A Forward P/E Ratio37.69 P/E GrowthN/ANet Income$-113,040,000.00 Net Margins-5.76% Pretax Margin-10.31% Return on Equity6.60% Return on Assets2.73% Debt Debt-to-Equity Ratio0.56 Current Ratio1.01 Quick Ratio1.01 Sales & Book Value Annual Sales$1.96 billion Price / Sales1.93 Cash Flow$1.82 per share Price / Cash Flow18.00 Book Value$9.38 per share Price / Book3.50Miscellaneous Outstanding Shares115,430,000Free Float111,621,000Market Cap$3.78 billion OptionableOptionable Beta1.54 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Seth Barrie Blackley (Age 45)Co-Founder, CEO & Director Comp: $1.79MMr. Dan McCarthy (Age 39)CEO of New Century Health & President Comp: $1.29MMr. John Paul Johnson (Age 40)Chief Financial Officer Comp: $994.22kMr. Jonathan David Weinberg J.D. (Age 56)Chief Legal Officer, General Counsel & Secretary Comp: $696.07kMs. Emily Rafferty (Age 41)Chief Operating Officer Mr. Aammaad Shams (Age 40)Chief Accounting Officer Comp: $341.78kMr. Robert CruzChief Technology OfficerMs. Jessica WhiteChief Information OfficerMr. Seth R. FrankVice President of Investor RelationsMs. Kali BeyahChief People & Brand OfficerMore ExecutivesKey CompetitorsAdvanced Energy IndustriesNASDAQ:AEISTeradataNYSE:TDCDXC TechnologyNYSE:DXCSynapticsNASDAQ:SYNABlackbaudNASDAQ:BLKBView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 226,691 shares on 3/11/2024Ownership: 9.375%ICA Group Wealth Management LLCBought 1,000 shares on 3/8/2024Ownership: 0.001%Wellington Management Group LLPBought 4,073,959 shares on 3/5/2024Ownership: 7.202%Goldman Sachs Group Inc.Bought 801 shares on 3/1/2024Ownership: 0.590%Chicago Partners Investment Group LLCBought 7,351 shares on 2/23/2024Ownership: 0.006%View All Insider TransactionsView All Institutional Transactions EVH Stock Analysis - Frequently Asked Questions Should I buy or sell Evolent Health stock right now? 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last twelve months. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVH shares. View EVH analyst ratings or view top-rated stocks. What is Evolent Health's stock price target for 2024? 12 brokers have issued 1 year target prices for Evolent Health's shares. Their EVH share price targets range from $34.00 to $52.00. On average, they anticipate the company's share price to reach $42.70 in the next twelve months. This suggests a possible upside of 30.2% from the stock's current price. View analysts price targets for EVH or view top-rated stocks among Wall Street analysts. How have EVH shares performed in 2024? Evolent Health's stock was trading at $33.03 at the beginning of 2024. Since then, EVH shares have decreased by 0.7% and is now trading at $32.79. View the best growth stocks for 2024 here. When is Evolent Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our EVH earnings forecast. How were Evolent Health's earnings last quarter? Evolent Health, Inc. (NYSE:EVH) posted its earnings results on Thursday, February, 22nd. The technology company reported $0.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.02 by $0.13. The technology company had revenue of $556.06 million for the quarter, compared to the consensus estimate of $541.87 million. Evolent Health had a positive trailing twelve-month return on equity of 6.60% and a negative net margin of 5.76%. What ETFs hold Evolent Health's stock? ETFs with the largest weight of Evolent Health (NYSE:EVH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Harbor Corporate Culture Small Cap ETF (HAPS), Fidelity Disruptive Medicine ETF (FMED), Harbor Small Cap Explorer ETF (QWST).LeaderShares Activist Leaders ETF (ACTV) and What guidance has Evolent Health issued on next quarter's earnings? Evolent Health updated its FY 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.4 billion-$2.5 billion, compared to the consensus revenue estimate of $2.3 billion. What is Seth Blackley's approval rating as Evolent Health's CEO? 12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX). When did Evolent Health IPO? Evolent Health (EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Evolent Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.41%), Vanguard Group Inc. (9.37%), Wellington Management Group LLP (7.20%), Granahan Investment Management LLC (2.53%), Point72 Asset Management L.P. (2.33%) and Bellevue Group AG (2.07%). Insiders that own company stock include Cheryl Scott, Daniel Joseph Mccarthy, Diane Holder, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:EVH) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.